Semax Neuroprotection, Bleeding Risk & Amphetamine Interactions
What preclinical studies, limited human reports, and FDA review show about Semax neuroprotection and unresolved bleeding and stimulant-interaction risks.
Research library
Peptide Research
Articles
Evidence-first insights on peptide protocols, emerging research, and the science shaping what comes next.
Accumark Labs Review: Is This Peptide Testing Lab Legit?
We followed one Omni Peptides BPC-157 COA through Accumark's live verification portal, then examined what its HPLC, identity and quantity results establish—and which tests are absent.
Tirzepatide Cardiovascular Risk: FDA Expands Mounjaro Label
What the new cardiovascular indication means, how SURPASS-CVOT was designed, and why noninferiority to dulaglutide is not the same as superiority.
New Peptide Vendor COA Grades: August 2026 Release
The v2.5 review grades 39 vendor testing programs, explains why overall scores moved lower, and examines the peptide market's heavy reliance on ILS Labs.
Does Epitalon Increase Cancer Risk? Telomerase, Tumor and FDA Evidence
What the 2003 and 2025 cell studies, rodent tumor data, limited human evidence, and FDA's 2026 review actually show about Epitalon and cancer risk.
Does Shaking Damage Reconstituted Peptides? HPLC & LC-MS Evidence
A critical reading of one three-vial retatrutide comparison—and why stable HPLC area purity does not prove universal stability or unchanged potency.
Gray-Market Retatrutide: Real-World EHR Data
What a large U.S. health-record study found about products purported to contain retatrutide, weight loss, heart rate, symptom signals, and major evidence limits.
SLU-PP-332 vs SLU-PP-915: What the Published Data Show
A primary-source comparison of ERR potency, oral exposure, mouse endurance research, cardiac findings, and the evidence that remains missing.
MOTS-C Stability After Reconstitution: 30-Day Data
A critical reading of refrigerated MOTS-C purity and volume measurements—and why they do not establish potency, sterility, or a universal shelf life.
BPC-157 Stability After Reconstitution: 90-Day Data
How to interpret long-term BPC-157 stability claims without confusing chemical purity, potency, aggregation, and sterility.
ATX-304 (O304): Human Trials, AMPK Mechanism & Evidence
An evidence-focused look at this investigational AMPK and mitochondrial activator, including the important limits behind its early human findings.
How Peptide Protocols COA Grades Work
How we evaluate vendor testing programs, validate laboratories and reports, handle missing evidence, and translate the testing trail into a COA Grade.
What Are Peptides? A Beginner's Guide to Peptide Research
A practical introduction to peptide biology, research evidence, protocols, product quality, and the questions worth answering before comparing compounds.